Treatment of chronic Chagas' disease with itraconazole and allopurinol
- PMID: 9684641
- DOI: 10.4269/ajtmh.1998.59.133
Treatment of chronic Chagas' disease with itraconazole and allopurinol
Abstract
Four hundred four patients with chronic Chagas' disease were treated with itraconazole (6 mg/kg of body weight/day for 120 days), allopurinol (8.5 mg/kg of body weight/day for 60 days), or with a placebo of pure starch. Patients were monitored over a period of four years by clinical examination, serology, xenodiagnosis, hemoculture, and electrocardiogram. Drug tolerance was good, with only four treatments discontinued due to side effects that subsided after suspension of treatment. Parasitologic cure was evident in 44% of the those treated with allopurinol and 53% of those treated with itraconazole, and the electrocardiographic evaluation showed normalization in 36.5% and 48.2%, respectively, of patients with chronic or recent cardiopathy.
Similar articles
-
Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the results of clinical and parasitological examinations 11 years post-treatment.Ann Trop Med Parasitol. 2005 Dec;99(8):733-41. doi: 10.1179/136485905X75403. Ann Trop Med Parasitol. 2005. PMID: 16297286
-
Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the regression and prevention of electrocardiographic abnormalities during 9 years of follow-up.Ann Trop Med Parasitol. 2003 Jan;97(1):23-9. doi: 10.1179/000349803125002751. Ann Trop Med Parasitol. 2003. PMID: 12662419 Clinical Trial.
-
[Treatment of chronic human Chagas disease with itraconazole and allopurinol. Preliminary report].Rev Med Chil. 1994 Apr;122(4):420-7. Rev Med Chil. 1994. PMID: 7809537 Clinical Trial. Spanish.
-
Acute Chagas' cardiopathy in a polar bear (Ursus maritimus) in Guadalajara, Mexico.Rev Soc Bras Med Trop. 1997 Jul-Aug;30(4):337-40. doi: 10.1590/s0037-86821997000400011. Rev Soc Bras Med Trop. 1997. PMID: 9219444 Review.
-
[Update on the treatment of Chagas' disease].Rev Med Chil. 2011 Feb;139(2):247-57. Epub 2011 Jul 11. Rev Med Chil. 2011. PMID: 21773664 Review. Spanish.
Cited by
-
Benznidazole/Itraconazole Combination Treatment Enhances Anti-Trypanosoma cruzi Activity in Experimental Chagas Disease.PLoS One. 2015 Jun 15;10(6):e0128707. doi: 10.1371/journal.pone.0128707. eCollection 2015. PLoS One. 2015. PMID: 26076455 Free PMC article.
-
Targeting Trypanosoma cruzi sterol 14α-demethylase (CYP51).Adv Parasitol. 2011;75:65-87. doi: 10.1016/B978-0-12-385863-4.00004-6. Adv Parasitol. 2011. PMID: 21820552 Free PMC article. Review.
-
In vivo activity of (8-hydroxymethylen)-trieicosanyl acetate against Trypanosoma cruzi during acute phase of the infection.Afr J Tradit Complement Altern Med. 2011;8(5 Suppl):198-207. doi: 10.4314/ajtcam.v8i5S.26. Epub 2011 Jul 3. Afr J Tradit Complement Altern Med. 2011. PMID: 22754075 Free PMC article.
-
Mannose-binding lectin and Toll-like receptor polymorphisms and Chagas disease in Chile.Am J Trop Med Hyg. 2012 Feb;86(2):229-32. doi: 10.4269/ajtmh.2012.11-0539. Am J Trop Med Hyg. 2012. PMID: 22302853 Free PMC article.
-
Clinical aspects of Chagas disease and implications for novel therapies.Drug Dev Res. 2011 Sep;72(6):471-479. doi: 10.1002/ddr.20454. Drug Dev Res. 2011. PMID: 22267887 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical